Toronto Dominion Bank
DMAAR

Toronto Dominion Bank’s Drugs Made In America Acquisition Corp Rights DMAAR Stock Holding History

Toronto Dominion Bank’s Portfolio DMAAR Stock Details DMAAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.4K Sell
690,000
-313,000
-31% -$33.1K ﹤0.01% 1794
2025
Q4 		$188K Buy
1,003,000
+3,000
+0.3% +$582 ﹤0.01% 1482
2025
Q3 		$217K Sell
1,000,000
-945,600
-49% -$176K ﹤0.01% 1391
2025
Q2 		$234K Buy
+1,945,600
New +$250K ﹤0.01% 1276

Other funds holding DMAAR

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Toronto Dominion Bank's DMAAR Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Drugs Made In America Acquisition Corp Rights (DMAAR) stake by 31% in Q1 2026, selling an estimated $33.1K and leaving 690,000 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

Toronto Dominion Bank first reported a position in DMAAR in Q2 2025 and has held it in 4 quarters since. The position peaked at $234K in Q2 2025. 35 funds tracked by Wall St. Rank hold DMAAR as of Q1 2026.

  • Toronto Dominion Bank held 690,000 shares of Drugs Made In America Acquisition Corp Rights worth $41.4K as of Q1 2026.
  • Toronto Dominion Bank sold 313,000 Drugs Made In America Acquisition Corp Rights shares in Q1 2026, an estimated $33.1K.
  • Drugs Made In America Acquisition Corp Rights made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1794 holding.
  • Toronto Dominion Bank first reported a position in Drugs Made In America Acquisition Corp Rights in Q2 2025 and has held it in 4 quarters since.
  • Toronto Dominion Bank's Drugs Made In America Acquisition Corp Rights position peaked at $234K in Q2 2025.
  • 35 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Rights as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.